Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects
- 31 March 1990
- journal article
- Published by Elsevier BV in Antiviral Research
- Vol. 13 (3), 127-138
- https://doi.org/10.1016/0166-3542(90)90028-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged TherapyScience, 1989
- EFFECTS OF ZIDOVUDINE IN 365 CONSECUTIVE PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1988
- Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trialArchives of Internal Medicine, 1988
- ZIDOVUDINE-ASSOCIATED MYOPATHYThe Lancet, 1988
- Numbers of CD4+ Cells and the Levels of Core Antigens of and Antibodies to the Human Immunodeficiency Virus as Predictors of AIDS Among Seropositive Homosexual MenThe Journal of Infectious Diseases, 1988
- EFFECT OF ZIDOVUDINE ON SERUM HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN LEVELS IN SYMPTOM-FREE SUBJECTSThe Lancet, 1988
- Azidothymidine Associated with Bone Marrow Failure in the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Significant Changes in HIV Antigen Level in the Serum of Patients Treated with AzidothymidineNew England Journal of Medicine, 1986
- Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.BMJ, 1986